Transapical Implantation of a 2nd-Generation JenaValve Device in Patient with Extremely High Surgical Risk.
Transcatheter Aortic Valve Replacement (TAVR) is performed in patients who are poor surgical candidates. Many patients have inadequate femoral access, and alternative access sites have been used such as the transapical approach discussed in this paper. We present an elderly and fragile patient not suitable for surgery for unacceptable high risk, including poor ventricular function, previous myocardial infarction with percutaneous coronary intervention, pericardial effusion, and previous cardiac surgery with replacement of mechanical mitral valve. Transapical aortic valve replacement with a second-generation self-expanding JenaValve is performed. The JenaValve is a second-generation transapical TAVR valve consisting of a porcine root valve mounted on a low-profile nitinol stent. The valve is fully retrievable and repositionable. We discuss transapical access, implantation technique, and feasibility of valve implantation in this extremely high surgical risk patient.
Cardiac Unit and Cardiovascular Surgery Department, Otamendi Hospital, Azcuènaga 870, C1115AAB Buenos Aires, Argentina.
Juan
J
Mieres
Cardiac Unit and Cardiovascular Surgery Department, Otamendi Hospital, Azcuènaga 870, C1115AAB Buenos Aires, Argentina.
Marcelo
M
Menéndez
Cardiac Unit and Cardiovascular Surgery Department, Otamendi Hospital, Azcuènaga 870, C1115AAB Buenos Aires, Argentina.
Carlos
C
Fernández-Pereira
Cardiac Unit and Cardiovascular Surgery Department, Otamendi Hospital, Azcuènaga 870, C1115AAB Buenos Aires, Argentina.
Miguel
M
Rubio
Cardiac Unit and Cardiovascular Surgery Department, Otamendi Hospital, Azcuènaga 870, C1115AAB Buenos Aires, Argentina.
Alfredo E
AE
Rodríguez